Zobrazit v EDS

Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.

Uloženo v:
Podrobná bibliografie
Název: Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.
Autoři: Bonanni, Paolo, Heo, Jung Yeon, Honda, Hitoshi, Lee, Ping-Ing, Mouliom, Aminatou, Leong, Hoe Nam, del Pilar Martin Matos, Maria, Dawson, Rachel
Zdroj: Infectious Diseases & Therapy; May2025, Vol. 14 Issue 5, p911-932, 22p
Témata: MEDICAL personnel, RESPIRATORY infections, VACCINE effectiveness, MEDICAL sciences, RESPIRATORY syncytial virus
Abstrakt: Lower respiratory tract infections caused by SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) cause a significant disease burden globally, despite the availability of effective vaccines. Certain populations, such as older adults (≥ 60 years) and individuals of all ages with particular comorbidities, are at increased risk for severe outcomes, including hospitalization and death. National administration schedules for available vaccines against respiratory viruses are not unified, and not all current guidelines are clear and directive, concerning the optimal timing of vaccination. Herein, we formulate an evidence-based position regarding the optimal timing of COVID-19, influenza, and RSV vaccination for older adults and individuals with chronic comorbidities, based on a synthesis of the literature and current guidelines. Vaccination impact and timing were found to be influenced by vaccinee risk factors, including age and comorbidities, and waning vaccine effectiveness and seasonal pathogen burden. Because COVID-19, influenza, and RSV display unique seasonal patterns within and between regions, local epidemiological surveillance of each virus is crucial for determining optimal vaccination timing and guidelines. To maximize the benefits of these respiratory virus vaccines, the timing of peak vaccine effectiveness and period of greatest risk for severe outcomes should be aligned. Thus, COVID-19, influenza, and other recommended vaccines given ahead of the start of the respiratory virus season (or other regionally appropriate time) and co-administered at a single, routine visit represent the optimal approach to protecting at-risk populations. More data will be required to establish the clinical benefit of additional RSV vaccine doses and whether these may be integrated within a seasonal schedule. Coordinated policy decisions that align with strain selection for new and annually reformulated vaccines would enable the timely raising of public health awareness, ultimately leading to enhanced vaccine uptake. Implementation strategies will require engagement of healthcare providers and strong, evidence-based public health recommendations for integrated vaccine schedules. [ABSTRACT FROM AUTHOR]
Copyright of Infectious Diseases & Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáze: Biomedical Index
FullText Text:
  Availability: 0
CustomLinks:
  – Url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pmc&term=2193-8229[TA]+AND+911[PG]+AND+2025[PDAT]
    Name: FREE - PubMed Central (ISSN based link)
    Category: fullText
    Text: Full Text
    Icon: https://imageserver.ebscohost.com/NetImages/iconPdf.gif
    MouseOverText: Check this PubMed for the article full text.
  – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edm&genre=article&issn=21938229&ISBN=&volume=14&issue=5&date=20250501&spage=911&pages=911-932&title=Infectious Diseases & Therapy&atitle=Optimal%20Timing%20of%20Vaccination%3A%20A%20Narrative%20Review%20of%20Integrating%20Strategies%20for%20COVID-19%2C%20Influenza%2C%20and%20Respiratory%20Syncytial%20Virus.&aulast=Bonanni%2C%20Paolo&id=DOI:10.1007/s40121-025-01135-0
    Name: Full Text Finder
    Category: fullText
    Text: Full Text Finder
    Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif
    MouseOverText: Full Text Finder
  – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Bonanni%20P
    Name: ISI
    Category: fullText
    Text: Nájsť tento článok vo Web of Science
    Icon: https://imagesrvr.epnet.com/ls/20docs.gif
    MouseOverText: Nájsť tento článok vo Web of Science
Header DbId: edm
DbLabel: Biomedical Index
An: 185239850
RelevancyScore: 1041
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1040.79272460938
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bonanni%2C+Paolo%22">Bonanni, Paolo</searchLink><br /><searchLink fieldCode="AR" term="%22Heo%2C+Jung+Yeon%22">Heo, Jung Yeon</searchLink><br /><searchLink fieldCode="AR" term="%22Honda%2C+Hitoshi%22">Honda, Hitoshi</searchLink><br /><searchLink fieldCode="AR" term="%22Lee%2C+Ping-Ing%22">Lee, Ping-Ing</searchLink><br /><searchLink fieldCode="AR" term="%22Mouliom%2C+Aminatou%22">Mouliom, Aminatou</searchLink><br /><searchLink fieldCode="AR" term="%22Leong%2C+Hoe+Nam%22">Leong, Hoe Nam</searchLink><br /><searchLink fieldCode="AR" term="%22del+Pilar+Martin+Matos%2C+Maria%22">del Pilar Martin Matos, Maria</searchLink><br /><searchLink fieldCode="AR" term="%22Dawson%2C+Rachel%22">Dawson, Rachel</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Infectious Diseases & Therapy; May2025, Vol. 14 Issue 5, p911-932, 22p
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MEDICAL+personnel%22">MEDICAL personnel</searchLink><br /><searchLink fieldCode="DE" term="%22RESPIRATORY+infections%22">RESPIRATORY infections</searchLink><br /><searchLink fieldCode="DE" term="%22VACCINE+effectiveness%22">VACCINE effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22MEDICAL+sciences%22">MEDICAL sciences</searchLink><br /><searchLink fieldCode="DE" term="%22RESPIRATORY+syncytial+virus%22">RESPIRATORY syncytial virus</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Lower respiratory tract infections caused by SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) cause a significant disease burden globally, despite the availability of effective vaccines. Certain populations, such as older adults (≥ 60 years) and individuals of all ages with particular comorbidities, are at increased risk for severe outcomes, including hospitalization and death. National administration schedules for available vaccines against respiratory viruses are not unified, and not all current guidelines are clear and directive, concerning the optimal timing of vaccination. Herein, we formulate an evidence-based position regarding the optimal timing of COVID-19, influenza, and RSV vaccination for older adults and individuals with chronic comorbidities, based on a synthesis of the literature and current guidelines. Vaccination impact and timing were found to be influenced by vaccinee risk factors, including age and comorbidities, and waning vaccine effectiveness and seasonal pathogen burden. Because COVID-19, influenza, and RSV display unique seasonal patterns within and between regions, local epidemiological surveillance of each virus is crucial for determining optimal vaccination timing and guidelines. To maximize the benefits of these respiratory virus vaccines, the timing of peak vaccine effectiveness and period of greatest risk for severe outcomes should be aligned. Thus, COVID-19, influenza, and other recommended vaccines given ahead of the start of the respiratory virus season (or other regionally appropriate time) and co-administered at a single, routine visit represent the optimal approach to protecting at-risk populations. More data will be required to establish the clinical benefit of additional RSV vaccine doses and whether these may be integrated within a seasonal schedule. Coordinated policy decisions that align with strain selection for new and annually reformulated vaccines would enable the timely raising of public health awareness, ultimately leading to enhanced vaccine uptake. Implementation strategies will require engagement of healthcare providers and strong, evidence-based public health recommendations for integrated vaccine schedules. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label:
  Group: Ab
  Data: <i>Copyright of Infectious Diseases & Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edm&AN=185239850
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-025-01135-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 22
        StartPage: 911
    Subjects:
      – SubjectFull: MEDICAL personnel
        Type: general
      – SubjectFull: RESPIRATORY infections
        Type: general
      – SubjectFull: VACCINE effectiveness
        Type: general
      – SubjectFull: MEDICAL sciences
        Type: general
      – SubjectFull: RESPIRATORY syncytial virus
        Type: general
    Titles:
      – TitleFull: Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bonanni, Paolo
      – PersonEntity:
          Name:
            NameFull: Heo, Jung Yeon
      – PersonEntity:
          Name:
            NameFull: Honda, Hitoshi
      – PersonEntity:
          Name:
            NameFull: Lee, Ping-Ing
      – PersonEntity:
          Name:
            NameFull: Mouliom, Aminatou
      – PersonEntity:
          Name:
            NameFull: Leong, Hoe Nam
      – PersonEntity:
          Name:
            NameFull: del Pilar Martin Matos, Maria
      – PersonEntity:
          Name:
            NameFull: Dawson, Rachel
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21938229
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Infectious Diseases & Therapy
              Type: main
ResultId 1